Browsing by Subject "Cerebral Infarction"

Now showing items 1-4 of 4

    • Aprotinin improves functional outcome but not cerebral infarct size in an experimental model of stroke during cardiopulmonary bypass. 

      Homi, H Mayumi; Sheng, Huaxin; Arepally, Gowthami M; Mackensen, G Burkhard; Grocott, Hilary P (Anesthesia and analgesia, 2010-07)
      <h4>Background</h4>Aprotinin, a nonspecific serine protease inhibitor, has been used to decrease bleeding and reduce the systemic inflammatory response after cardiopulmonary bypass (CPB). Studies have variably linked aprotinin ...

    • Development and initial testing of the stroke rapid-treatment readiness tool. 

      Olson, DaiWai M; Cox, Margueritte; Constable, Mark; Britz, Gavin W; Lin, Cheryl B; Zimmer, Louise O; Fonarow, Gregg C; ... (9 authors) (J Neurosci Nurs, 2014-10)
      No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic ...

    • Report of a young girl with MYH9 mutation and review of the literature. 

      Landi, Daniel; Lockhart, Evelyn; Miller, Sara E; Datto, Michael; Rehder, Catherine; Kanaly, Angela; Thornburg, Courtney D (Journal of pediatric hematology/oncology, 2012-10)
      MYH9 mutations cause the inherited macro-thrombocytopenic syndromes of May-Hegglin anomaly, Fechtner syndrome, Sebastian syndrome, and Epstein syndrome, collectively referred to as MYH9-related disease. We present the case ...

    • Visual memory-deficit amnesia: a distinct amnesic presentation and etiology. 

      Rubin, DC; Greenberg, DL (Proc Natl Acad Sci U S A, 1998-04-28)
      We describe a form of amnesia, which we have called visual memory-deficit amnesia, that is caused by damage to areas of the visual system that store visual information. Because it is caused by a deficit in access to stored ...